Trump's New Deal Cuts Obesity Drug Prices but Sparks Concerns
TL;DR Summary
The US is planning to reduce the prices of obesity drugs that are offered on a website associated with Trump, aiming to make these medications more affordable.
- US to slash prices of obesity drugs offered on Trump website Financial Times
- Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage CNBC
- Trump announces deal to sell some weight loss drugs for as low as $150 on TrumpRX WBFF
- Trump’s Ozempic Deal Has a Major Flaw The Atlantic
- Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic Fortune
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
1 min
vs 1 min read
Condensed
79%
128 → 27 words
Want the full story? Read the original article
Read on Financial Times